Evidence map›Paper›PMID 31979014›Full record

ReviewToxins2020

Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways.

Philip E Bickler

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06703645 (Evaluation of Snakebite Cases in Assiut Governorate, Egypt), which is not on this map. Cited by 50 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06703645 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of Snakebite Cases in Assiut Governorate, Egypt (Prospective Study)

Typeobservational_patient_registrySponsorAssiut UniversityRan2024 to 2026Enrolled49ConditionsSnakebite Cases Evaluation Clinical and Laboratory
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 3 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Frontiers in immunology · 2020
    Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Thromboinflammatory complications ofFrontiers in immunology · 2025
    Review
  15. Review
  16. Article
  17. Characterization of plant produced VBiotechnology reports (Amsterdam, Netherlands) · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Philip E BicklerDepartment of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, CA 94143-0542, USA.
California Academy of Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The active components of snake venoms encompass a complex and variable mixture of proteins that produce a diverse, but largely stereotypical, range of pharmacologic effects and toxicities. Venom protein diversity and host susceptibilities determine the relative contributions of five main pathologies: neuromuscular dysfunction, inflammation, coagulopathy, cell/organ injury, and disruption of homeostatic mechanisms of normal physiology. In this review, we describe how snakebite is not only a condition mediated directly by venom, but by the amplification of signals dysregulating inflammation, coagulation, neurotransmission, and cell survival. Although venom proteins are diverse, the majority of important pathologic events following envenoming follow from a small group of enzyme-like activities and the actions of small toxic peptides. This review focuses on two of the most important enzymatic activities: snake venom phospholipases (svPLA

Indexed as

AnimalsBlood CoagulationHumansInflammationMetalloproteasesPhospholipases A2, SecretoryReptilian ProteinsSignal TransductionSnake VenomsMetalloproteasesPhospholipases A2, SecretoryReptilian ProteinsSnake Venomsintracellular calciumintracellular signalingmetalloproteaseneuromuscular paralysisphospholipase A2snake venom

Identifiers

PMID31979014
PMCPMC7076764
OpenAlexW3003488099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.